CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
No relevant cardiac, pharmacokinetic or safety interactions between roflumilast and inhaled formoterol in healthy subjects: an open-label, randomised, actively controlled study
Authors
A Buenestado
A Hatzelmann
+56Â more
A Hatzelmann
AM Weissler
BR Celli
C de Mey
C de Mey
C de Mey
C de Mey
C de Mey
C de Mey
C de Mey
Christian de Mey
D Spina
D Spina
DA Kirby
DC Grootendorst
DE O'Donnell
DS Bundschuh
E Carlsson
ED Bateman
Electronic Medicines Compendium
G Jonsson
G Lahu
G Lahu
G Lahu
G Lahu
Gezim Lahu
Global Initiative for Chronic Obstructive Lung Disease
GM Bohmer
GP Anderson
HC Bazett
JA Bennett
JB Lecaillon
JL Hodges
K Wezler
KF Rabe
LA Geddes
LM Fabbri
LS Fridericia
M Cazzola
M David
M Palmqvist
M Zaccolo
N Nassr
NA Jones
Nassr Nassr
O von Richter
PM Calverley
PM Calverley
PM Calverley
R Hermann
R Hermann
R Hermann
R Hermann
SI Rennard
TD Bethke
WG Kubicek
Publication date
1 January 2011
Publisher
BioMed Central
Doi
Cite
View
on
PubMed
Abstract
Abstract is not available.
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Springer - Publisher Connector
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 28/04/2017
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 05/06/2019